[go: up one dir, main page]

BG61321B2 - (1н-имидазол-1-илметил) заместени бензимидазолови производни - Google Patents

(1н-имидазол-1-илметил) заместени бензимидазолови производни Download PDF

Info

Publication number
BG61321B2
BG61321B2 BG097951A BG9795193A BG61321B2 BG 61321 B2 BG61321 B2 BG 61321B2 BG 097951 A BG097951 A BG 097951A BG 9795193 A BG9795193 A BG 9795193A BG 61321 B2 BG61321 B2 BG 61321B2
Authority
BG
Bulgaria
Prior art keywords
parts
formula
alkyl
compound
imidazol
Prior art date
Application number
BG097951A
Other languages
Bulgarian (bg)
English (en)
Inventor
Alfons Raeymaekers
Eddy Freyne
Gerard Sanz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG61321B2 publication Critical patent/BG61321B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG097951A 1986-09-15 1993-07-15 (1н-имидазол-1-илметил) заместени бензимидазолови производни BG61321B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90790386A 1986-09-15 1986-09-15

Publications (1)

Publication Number Publication Date
BG61321B2 true BG61321B2 (bg) 1997-05-30

Family

ID=25424835

Family Applications (1)

Application Number Title Priority Date Filing Date
BG097951A BG61321B2 (bg) 1986-09-15 1993-07-15 (1н-имидазол-1-илметил) заместени бензимидазолови производни

Country Status (23)

Country Link
EP (1) EP0260744B1 (el)
JP (1) JPS6485975A (el)
KR (1) KR960014353B1 (el)
CN (1) CN1020903C (el)
AU (1) AU595064B2 (el)
BG (1) BG61321B2 (el)
CA (1) CA1323366C (el)
CY (1) CY1803A (el)
DE (1) DE3783107T2 (el)
DK (1) DK174728B1 (el)
ES (1) ES2053524T3 (el)
FI (1) FI87781C (el)
GR (1) GR3006841T3 (el)
HK (1) HK123694A (el)
HU (1) HU198039B (el)
IE (1) IE60514B1 (el)
IL (1) IL83892A (el)
NO (1) NO167202C (el)
NZ (1) NZ221729A (el)
PH (1) PH25022A (el)
PT (1) PT85692B (el)
SU (1) SU1662350A3 (el)
ZA (1) ZA876881B (el)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
US5021448A (en) * 1990-02-22 1991-06-04 Ciba-Geigy Corporation Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
FR2663028B1 (fr) * 1990-06-08 1994-10-14 Roussel Uclaf Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5216003A (en) * 1992-01-02 1993-06-01 G. D. Searle & Co. Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
WO1995004723A1 (fr) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive
WO1995009157A1 (en) * 1993-09-30 1995-04-06 Yamanouchi Pharmaceutical Co., Ltd. Azole derivative and pharmaceutical composition thereof
SG47122A1 (en) * 1994-02-18 1998-03-20 Janssen Pharmaceutica Nv Enantiomerically pure(-)-liarozole
JPH09508914A (ja) * 1994-02-18 1997-09-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 鏡像異性体的に純粋な（＋）−リアロゾール
GB9418443D0 (en) * 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
US5688810A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US6696459B1 (en) 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
EP1041066A1 (en) * 1994-12-22 2000-10-04 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
TW316902B (el) * 1994-12-28 1997-10-01 Janssen Pharmaceutica Nv
PL322028A1 (en) * 1995-03-01 1998-01-05 Yamanouchi Pharma Co Ltd Derivatives of imidazoles and pharmaceutic composition containing them
US6288100B1 (en) * 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
DE19535500A1 (de) * 1995-09-25 1997-03-27 Bayer Ag Verfahren zur Herstellung von 3-Chlor-3'-nitro-4'-methoxybenzophenon
JP3063162B2 (ja) * 1995-12-28 2000-07-12 藤沢薬品工業株式会社 ベンズイミダゾール誘導体
KR100365312B1 (ko) * 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
CN1104422C (zh) * 1996-11-25 2003-04-02 普罗克特和甘保尔公司 用作α－2肾上腺素能受体兴奋剂的胍基杂环化合物
AU6229698A (en) 1997-02-21 1998-09-09 Takeda Chemical Industries Ltd. Fused ring compounds, process for producing the same and use thereof
TW453999B (en) 1997-06-27 2001-09-11 Fujisawa Pharmaceutical Co Benzimidazole derivatives
PT1037880E (pt) 1997-12-11 2004-11-30 Janssen Pharmaceutica Nv Anilidas mimeticas do acido retinoico
DE19831985A1 (de) 1998-07-16 2000-01-20 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
JP2003501418A (ja) * 1999-06-04 2003-01-14 エラン ファーマ インターナショナル，リミティド 細胞死を阻害するための組成物および方法
EP1265853A1 (en) 2000-03-16 2002-12-18 F. Hoffmann-La Roche AG Carboxylic acid derivatives as ip antagonists
KR100725442B1 (ko) 2000-11-17 2007-06-07 다케다 야쿠힌 고교 가부시키가이샤 신규 이미다졸 유도체, 이의 제조 방법 및 이의 용도
ATE502030T1 (de) 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
CA2431171A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
US7405235B2 (en) 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US6492517B1 (en) * 2001-07-19 2002-12-10 Air Products And Chemicals, Inc. Method for preparing halomethyl heterocyclic compounds
CN101092400A (zh) * 2001-11-16 2007-12-26 日本化学医药株式会社 黄嘌呤氧化酶抑制剂
WO2004041209A2 (en) * 2002-11-01 2004-05-21 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
JP2007500245A (ja) * 2003-06-10 2007-01-11 スミスクライン ビーチャム コーポレーション 化合物
FR2860235A1 (fr) * 2003-09-29 2005-04-01 Yang Ji Chemical Company Ltd Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
WO2006076009A2 (en) 2004-04-23 2006-07-20 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
EP1805147B1 (en) * 2004-09-30 2014-08-13 Janssen Pharmaceutica NV Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
US7348438B2 (en) 2004-09-30 2008-03-25 Janssen Pharmaceutica N.V. Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
SI1984343T1 (sl) * 2006-01-24 2013-05-31 Janssen Pharmaceutica N.V. 2-substituirani benzimidazoli kot selektivni modulatorji androgenskih receptorjev (sarms)
EP1987028A2 (en) 2006-02-10 2008-11-05 Transtech Pharma, Inc. Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
KR101307497B1 (ko) * 2006-04-19 2013-09-11 주식회사 동진쎄미켐 디이미다졸계 화합물 및 이를 이용한 유기발광소자
CN100496308C (zh) * 2006-06-02 2009-06-10 上海烟草（集团）公司 造纸法再造烟叶半逆流多级萃取工艺
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives
JP5492075B2 (ja) * 2007-05-23 2014-05-14 アラーガン インコーポレイテッド アドレナリンレセプター作用薬としての（（二環式ヘテロアリール）イミダゾリル）メチルヘテロアリール化合物
DE102009038950A1 (de) 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue antiparasitäre Kombination von Wirkstoffen
WO2012052540A1 (en) * 2010-10-21 2012-04-26 Universitaet Des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
EP2760854B1 (en) * 2011-09-30 2017-08-30 Asana BioSciences, LLC Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
KR101884447B1 (ko) * 2015-07-06 2018-08-01 삼성에스디아이 주식회사 모노머, 유기막 조성물, 유기막, 및 패턴형성방법
JP2024536342A (ja) * 2021-10-04 2024-10-04 ボルト バイオセラピューティクス、インコーポレーテッド 非対称ビス－ベンゾイミダゾールｓｔｉｎｇアゴニスト免疫複合体及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (el) * 1980-10-23 1984-07-13 Pfizer
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
EP0178413A1 (en) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles

Also Published As

Publication number Publication date
FI87781B (fi) 1992-11-13
FI87781C (fi) 1993-02-25
NZ221729A (en) 1989-07-27
DK479487D0 (da) 1987-09-14
EP0260744A2 (en) 1988-03-23
AU7838587A (en) 1988-04-14
IE60514B1 (en) 1994-07-27
SU1662350A3 (ru) 1991-07-07
DE3783107D1 (de) 1993-01-28
NO873840L (no) 1988-03-16
FI873977A0 (fi) 1987-09-14
IL83892A (en) 1991-11-21
IE872487L (en) 1988-03-15
CA1323366C (en) 1993-10-19
DK479487A (da) 1988-03-16
CN1020903C (zh) 1993-05-26
PT85692B (pt) 1990-06-29
JPH0587071B2 (el) 1993-12-15
ZA876881B (en) 1989-04-26
GR3006841T3 (el) 1993-06-30
KR960014353B1 (ko) 1996-10-15
CN87106423A (zh) 1988-04-20
HUT45051A (en) 1988-05-30
DE3783107T2 (de) 1993-04-22
NO167202B (no) 1991-07-08
CY1803A (en) 1987-09-09
IL83892A0 (en) 1988-02-29
ES2053524T3 (es) 1994-08-01
DK174728B1 (da) 2003-10-06
HU198039B (en) 1989-07-28
PH25022A (en) 1991-01-28
FI873977A7 (fi) 1988-03-16
NO167202C (no) 1991-10-16
JPS6485975A (en) 1989-03-30
PT85692A (en) 1987-10-01
NO873840D0 (no) 1987-09-14
EP0260744B1 (en) 1992-12-16
HK123694A (en) 1994-11-18
EP0260744A3 (en) 1989-01-18
KR880003935A (ko) 1988-06-01
AU595064B2 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
BG61321B2 (bg) (1н-имидазол-1-илметил) заместени бензимидазолови производни
US4859684A (en) (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
BG60429B2 (bg) (1н-азол-1-илметил)заместени бензотриазолни производни
KR870001046B1 (ko) N-(4-피페리딘일) 비사이클 축합 2-이미다졸아민 유도체의 제조방법
EP1725544B1 (en) 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
CA2586179C (en) Sulfonyl benzimidazole derivatives
CZ101898A3 (cs) Imidazolové deriváty afinitní k alfa2 receptorům, způsob jejich přípravy a farmaceutické přípravky je obsahující
US5037829A (en) (1H-azol-1-ylmethyl) substituted quinazoline derivatives
RU2174513C2 (ru) Четырехзамещенные производные имидазола, способы их получения, промежуточные соединения и фармацевтическая композиция
US4943574A (en) (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
NO172438B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ((5(6)(1h-azol-1-ylmetyl)benzimidazol)karbamater
WO1996012706A1 (fr) Nouveaux derives de pyrazolones et pyrazoles acides utiles comme antagonistes pour les recepteurs a l'endotheline
KR960015004B1 (ko) (1h-이미다졸-1-일메틸)치환된 벤즈이미다졸 유도체의 제조방법
US4313953A (en) Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US5441954A (en) (1h-azol-1-ylmethyl) substituted quinoline derivatives
US5039677A (en) 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
PH26050A (en) (1H-azol-1=ylmethyl)substituted benzotriazole derivatives